ライフサイエンスコーパス: balanced salt solution

1 rs compared with tobramycin/dexamethasone or balanced salt solution.

2 c acid suspension (10 mg) prepared in 0.1 mL balanced salt solution.

3 (BPs), EDPs, bovine serum albumin (BSA), or balanced salt solution.

4 varied by altering the height of a bottle of balanced salt solution.

5 vate, in a calcium- and potassium-containing balanced salt solution.

6 hed cell matrix was returned to a serum-free balanced salt solution.

7 eye was given a subconjunctival injection of balanced salt solution.

8 eribleb injection of either TGF-beta or of a balanced salt solution.

9 ge needle connected to an elevated bottle of balanced salt solution.

10 Cells of C. albicans incubated in Hanks balanced salt solution (+/-10% bovine serum albumin [BSA

11 eafter corneas were administered with either balanced salt solution AAV5-naked vector, or AAV5-Id3 ve

12 rified PMNs were suspended in HEPES-buffered balanced salts solutions adjusted to pH 6.7, 7.2, 7.7, o

13 nique after 14 days of local endothelin-1 or balanced salt solution administration to the microvascul

14 was significantly higher than ECs exposed to balanced salt solution alone or to BSA (P < 0.05) in all

15 29 (600 microg) in balanced salt solution or balanced salt solution alone was injected intravitreally

16 ne serum, but the tissue can be washed using balanced salt solution and gently injected.

17 Incubation of lenses in low-K+ balanced salt solution and TC-199 medium, containing phy

18 The contralateral eye was injected with balanced salt solution as a control.

19 with that of 1% trifluorothymidine (TFT) and balanced salt solution as the vehicle control.

20 In a glucose-salt solution (Earle's balanced salt solution), asparagine (Asn) stimulates orn

21 ere randomized to receive intracameral TA or balanced salt solution at the end of surgery.

22 glomerular filtration (angiotensin II, Hanks Balanced Salt Solution, Bovine Serum Albumin), NL-D3 is

23 ws: group 1, an 8.0-mm diameter treated with balanced salt solution (BSS) and an 8.0-mm removal; grou

24 selected patients who received enoxaparin in balanced salt solution (BSS) during cataract surgery, wh

25 the temperature of the fragmatome tip in the balanced salt solution (BSS) increased from 22.0 to 24.0

26 Seprafilm also was soaked in balanced salt solution (BSS) incubated at 37 degrees C,

27 ction of hyaluronic acid (Healon) or sterile balanced salt solution (BSS) into the subretinal space o

28 temic gabapentinoids, chilled intraoperative balanced salt solution (BSS) irrigation, cycloplegia, an

29 An IVT injection of balanced salt solution (BSS) or lipopolysaccharide (LPS)

30 Six groups of rabbits had IVI of sterile balanced salt solution (BSS), MTX (400 microg), dexameth

31 elationships between T1 relaxation times and balanced salt solution (BSS), to simulate human vitreous

32 ), 5-fluorouracil (5-FU; 5 mg, 50 mg/mL), or balanced salt solution (BSS; 0.1 mL, control).

33 , Fort Worth, TX) ophthalmic suspension, and balanced salt solution (BSS; Alcon Laboratories).

34 rative VA, case length, vitreous substitute (balanced salt solution [BSS], gas, air, or oil), sclerot

35 Since detachments were created with balanced salt solution, by examination, all retinas had

36 ere incubated for 5, 10 or 20 min in Earle's balanced salt solution containing 1.2 mM tannic acid (to

37 rmed in the presence of elastin fragments or balanced salt solution (control).

38 Earle's balanced salts solution (EBSS) with limited NaCl concent

39 injection of 2.5 mg/mL collagenase type 2 in balanced salt solution followed 1 hour and 15 minutes la

40 raulic debridement was produced by injecting balanced salt solution forcefully into the subretinal sp

41 ter each of two inhalation exposures: Hanks' balanced salt solution (HBSS) and corn dust extract (CDE

42 as treated with EMD, AMEL, and PGA in Hank's balanced salt solution (HBSS) for 1, 3, and 24 hours.

43 d an unwrapped but unopened bottle of Hank's balanced salt solution (HBSS) grew O. anthropi.

44 chamber injections of either HSV-1 or Hanks' balanced salt solution (HBSS).

45 iene B4 [LTB4]), or negative control (Hanks' balanced salt solution [HBSS]).

46 ously replacing hemofiltration volume with a balanced salt solution (HF group).

47 tetracaine hydrochloride and subconjunctival balanced salt solution injection (Control group) or topi

48 x additional animals received either drug or balanced salt solution injections into normal eyes, and

49 ared to controls that received only peribleb balanced salt solution injections.

50 ats by injecting 0.25% sodium hyaluronate in balanced salt solution into the subretinal space.

51 ml 5-FU and 5 IU/ml dalteparin) and placebo (balanced salt solution) intravitreally applied during ro

52 , or as a 2-step (n = 6) procedure, in which balanced salt solution is first used to define the subre

53 Palomid 529 (600 microg) in balanced salt solution or balanced salt solution alone w

54 nodules compared with treatment with Hank's balanced salt solution or DCs transduced with rat HER-2/

55 tal eye, compared to the decrease induced by balanced salt solution or to the decrease in rabbits wit

56 NF) was prepared by incubating PMN in Hanks' balanced salt solution plus TNF-alpha for 1-4 hrs.

57 gel sieving on Sephacryl HR S500 in buffered balanced salts solution plus albumin.

58 mycin C (0.005 mg, 0.02 mg, and 0.08 mg) and balanced salt solution showed normal ciliary body epithe

59 injection of 2.5 mg/mL collagenase type 2 in balanced salt solution that was left in the stroma for 1

60 bility was tested by filling the globes with balanced salt solution through an anterior chamber port

61 administration of topical 2% epinephrine or balanced salt solution to six cynomolgus monkeys.

62 B homodimer as the chemoattractant and Hanks balanced salt solution to test random migration.

63 solution of rose bengal (0.1% or 0.2% RB in balanced salt solution) to the de-epithelialized cornea

64 with FST-100, tobramycin/dexamethasone, and balanced salt solution treatments.

65 rabbits) in a dosage of 0.1 microgram/day or balanced salt solution (two rabbits) was delivered to th

66 x 10(3) plaque forming unit in 0.1 ml Hank's balanced salt solution) was inoculated 4 days after gas

67 can hydrochloride (8-20 microg in 0.04 mL of balanced salt solution) was performed in 9 eyes, followe

68 age-matched male C57BL/6 mice injected with balanced salt solution were used as control subjects (fi

69 ular ATP formation was examined using Hanks' balanced salt solution with and without selective inhibi